Literature DB >> 3476806

[24-year survival in chronic myeloid leukemia].

L Müller, R Hehlmann.   

Abstract

A 55-year-old woman was diagnosed as having chronic myeloid leukemia in 1961. After 9 years with stable white blood cells, progression of the disease was noted (white cells up to 180 X 10(9)/l; splenomegaly to the umbilicus). Busulfan was given over 4 weeks resulting in a remission of 13 years duration. Progression was observed again in 1983, 22 years after the initial diagnosis of chronic myeloid leukemia. Therapy with hydroxyurea resulted in another remission of shorter duration. Two chromosome studies showed the Philadelphia chromosome in 100% of metaphases without additional aberrations. In 1985 blast crisis developed. The cause of death as determined at autopsy was an undiagnosed miliary tuberculosis. The presented case is of special interest since (1) it is a report of the longest surviving patient with chronic myeloid leukemia, and (2) in contrast to other cases with long survival, this patient did not show chromosomal mosaicism or any additional chromosomal aberrations.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3476806     DOI: 10.1007/BF01875503

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  16 in total

1.  Chromosomal mosaicism associated with prolonged remission in chronic myelogenous leukemia.

Authors:  D W Golde; N L Bersch; R S Sparkes
Journal:  Cancer       Date:  1976-04       Impact factor: 6.860

2.  [Survival time in chronic myelocytic leukemia dependent of individual disease-specific factor and therapy. Freiburg results 1947-1966].

Authors:  K Musshoff; L Boutis; P Obrecht; T Karsch
Journal:  Klin Wochenschr       Date:  1969-02-15

3.  Chronic granulocytic leukaemia with unusual long duration.

Authors:  K Rák; G Csapó; A Macher; G Török
Journal:  Folia Haematol (Frankf)       Date:  1964-10

4.  Prolonged remission in chronic myeloid leukemia after one course of busulfan.

Authors:  M Djaldetti; B Padeh; J Pinkhas; A De Vries
Journal:  Blood       Date:  1966-01       Impact factor: 22.113

5.  Eleven-year survival in a child with Philadelphia chromosome positive chronic granulocytic leukemia: case report.

Authors:  V A Kiley; R B Patterson; B A Parsley
Journal:  Mil Med       Date:  1983-01       Impact factor: 1.437

6.  Prognostic signs in chronic myelocytic leukemia.

Authors:  R F Schilling; J J Crowley
Journal:  Am J Hematol       Date:  1979       Impact factor: 10.047

7.  Prognostic discrimination in "good-risk" chronic granulocytic leukemia.

Authors:  J E Sokal; E B Cox; M Baccarani; S Tura; G A Gomez; J E Robertson; C Y Tso; T J Braun; B D Clarkson; F Cervantes
Journal:  Blood       Date:  1984-04       Impact factor: 22.113

8.  Active tuberculosis undiagnosed until autopsy.

Authors:  I D Bobrowitz
Journal:  Am J Med       Date:  1982-04       Impact factor: 4.965

9.  Prognostic features at diagnosis of chronic myelocytic leukemia.

Authors:  G A Gomez; J E Sokal; D Walsh
Journal:  Cancer       Date:  1981-05-15       Impact factor: 6.860

10.  Philadelphia chromosome-positive chronic myelocytic leukemia with a supplementary t(4;9)(q21;p22) and long survival.

Authors:  S A Tharapel; G I Plitman; A T Tharapel; R S Wilroy
Journal:  Cancer Genet Cytogenet       Date:  1986-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.